Cancer Immunology Immunotherapy
News
01 Nov 2022
Triple-negative breast cancer (TNBC) tumors gain immunosuppression and chemoresistance through interactions between interleukin 34 and myeloid-derived suppressor cells, researchers find.
Events
Sorry, no events coming up for this topic.
Researchers
Sorry, no researchers coming up for this topic.
Giants in history
Sorry, no researchers coming up for this topic.